You searched for metabolic diseases - Page 2 of 63

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

…involvement in various diseases – alterations in miRNA expression profiles have been linked to cancer, cardiovascular diseases, and neurodegenerative disorders. This connection positions miRNAs as both potential biomarkers for disease…

November 26, 2024 - 9 minutesmins - By Jules Adam

News and Trends 4 Nov 2024

Top biotech deals of October 2024

…in metabolic diseases continue As always, interest in targeting metabolic diseases remains strong. And once again, Lilly is in the game. It has partnered with insitro, a California-based drug company,…

November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter

Opinion 28 Feb 2023

Life changing treatments for rare disease – a beacon of hope

…across the medical spectrum and include cancers, neurological and neuromuscular diseases, metabolic diseases and a multitude of skin, bone, kidney, blood and skeletal disorders. Many have genetic origins, and some…

February 28, 2023 - 6 minutesmins - By External Contributor

In Depth 19 May 2023

Can cardiovascular diseases be cured? The future of heart treatment

…over the years increasing our understanding of different types of cardiovascular diseases and their causes. What are the challenges in developing cures for cardiovascular diseases? One of the main challenges…

May 19, 2023 - 11 minutesmins - By Willow Shah-Neville

Best in Biotech 29 Oct 2024

GPCR therapies: Eight promising biotechs hacking the cell signaling pathway

…of diseases like autoimmune disorder Graves’ disease – caused by excess thyroid hormone production – chronic spontaneous urticaria – a skin condition that causes hives – and metabolic diseases. Structure…

October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter

In Depth 25 Jan 2024

The trends that will shape the biotech industry in 2024

…mingled with other metabolic diseases, GLP-1 drugs will replace Lipitors. Furthermore, scientific findings about mitochondria are exciting as they show it is related to many diseases and complications. Aging relates…

January 25, 2024 - 13 minutesmins - By Jules Adam

20S proteasome activation: Berlin biotech Booster Therapeutics secures $15 million for innovative therapies to tackle neurodegenerative diseases

News and Trends 15 Oct 2024

Booster launches to treat neurodegenerative diseases with proteasome activation

…aggregated proteins. This strategy is particularly important for diseases where multiple proteinopathies – conditions caused by the accumulation of malfunctioning proteins – are present simultaneously, as seen in neurodegenerative diseases…

October 15, 2024 - 6 minutesmins - By Jules Adam

News and Trends 9 Jan 2017

Top European VC and CRO fund Young Metabolic Disease Biotech

…in Berlin focusing on the treatment of metabolic diseases. The company has now raised €8M in Series A, led by Scottish biotech VC Epidarex Capital. Among the investors was also…

January 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Jan 2020

AstraZeneca Recruits RNA Biotech to Develop Metabolic Disease Therapies

The UK biotech MiNA Therapeutics has launched a collaboration with AstraZeneca to develop small activating RNA drugs, which could treat metabolic diseases using targets unreachable by current medications. According to…

January 7, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 19 Jun 2017

This Company Uses the Human Microbiome to Discover New Disease Mechanisms

…role in health and also cause unprecedented damage by starting inflammatory cascades, leading to numerous metabolic diseases. Finding the Link And so, while everybody else was focusing on the human…

June 19, 2017 - 5 minutesmins - By External Contributor

Best in Biotech 28 Nov 2024

Six antisense oligonucleotide companies shaping the future of genetic medicine

…that TGF-β is chronically elevated in many diseases, including ophthalmic and fibrotic diseases and cancer, and involved in their pathophysiology, it is thought to be an extremely versatile drug target…

November 28, 2024 - 10 minutesmins - By Willow Shah-Neville

News and Trends 28 Feb 2023

What’s happening on Rare Disease Day?

…are recent advancements in rare diseases? “There are more than 8,000 known rare diseases that affect over 300 million people globally. Yet only a small percentage of these have treatments…

February 28, 2023 - 8 minutesmins - By Jim Cornall

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Seven miRNA-focused companies pioneering new therapies in 2024

Top biotech deals of October 2024

Life changing treatments for rare disease – a beacon of hope

Can cardiovascular diseases be cured? The future of heart treatment

GPCR therapies: Eight promising biotechs hacking the cell signaling pathway

The trends that will shape the biotech industry in 2024

Booster launches to treat neurodegenerative diseases with proteasome activation

Top European VC and CRO fund Young Metabolic Disease Biotech

AstraZeneca Recruits RNA Biotech to Develop Metabolic Disease Therapies

This Company Uses the Human Microbiome to Discover New Disease Mechanisms

Six antisense oligonucleotide companies shaping the future of genetic medicine

What’s happening on Rare Disease Day?

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!